Free Daily Analysis
Stock Trend Analysis Report
Prepared for you on Monday, December 11, 2023.
BridgeBio Pharma, Inc. (NASDAQ:BBIO)
Long-Term Uptrend (+90) - BBIO is in a strong uptrend that is likely to continue. While BBIO is showing intraday weakness, it remains in the confines of a bullish trend. Traders should use caution and utilize a stop order.
Is it time to buy, sell, or avoid BBIO?
MarketClub looks at technical strength and momentum to determine if the timing is right for BBIO.
Learn more about the Trade Triangles and how we make technical analysis as easy as buy and sell.
|
|||||||||||||||
|
|||||||||||||||
MarketClub’s Trade Triangles for BBIO
The long-term trend has been UP since Feb 6th, 2023 at 11.58
The intermediate-term trend has been UP since Nov 2nd, 2023 at 27.27
The short-term trend has been UP since Dec 4th, 2023 at 30.98
Smart Scan Analysis for BBIO
Based on our trend formula, BBIO is rated as a +90 on a scale from -100 (Strong Downtrend) to +100 (Strong Uptrend).
| Open | High | Low | Price | Change |
|---|---|---|---|---|
| 34.000 | 34.490 | 32.155 | 32.510 | -1.100 |
| Prev. Close | Volume | Bid | Ask | Time |
| 32.520 | 1060411 | 2023-12-08 15:59:00 |
| 52wk High | 36.36 | 52wk High Date | 2023-07-18 |
| 52wk Low | 6.64 | 52wk Low Date | 2022-12-28 |
| Average Volume | 1,266,000 | Shares Outstanding | 173,967 |
| Market Cap | 3,146M | Assets | 503,661,000M |
| Liabilities | 186,535,100M |